Evidence map›Paper›PMID 41675347›Full record

ArticleArXiv2026

A tissue-informed deep learning-based method for positron range correction in preclinical 68Ga PET imaging.

Nerea Encina-Baranda, Robert J Paneque-Yunta, Javier Lopez-Rodriguez, Edwin C Pratt, Trong Nghia Nguyen, Jan Grimm, Alejandro Lopez-Montes, Joaquin L Herraiz

Abstract readPreprint
In one paragraph

Article in ArXiv, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Nerea Encina-Baranda
Robert J Paneque-Yunta
Javier Lopez-Rodriguez
Edwin C Pratt
Trong Nghia Nguyen
Jan Grimm
Alejandro Lopez-Montes
Joaquin L Herraiz

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Positron range (PR) limits spatial resolution and quantitative accuracy in PET imaging, particularly for high-energy positron-emitting radionuclides like 68Ga. We propose a deep learning method using 3D residual encoder-decoder convolutional neural networks (3D RED-CNNs), incorporating tissue-dependent anatomical information through a u-map-dependent loss function. Models were trained with realistic simulations and, using initial PET and CT data, generated positron range corrected images. We validated the models in simulations and real acquisitions. Three 3D RED-CNN architectures, Single-channel, Two-channel, and DualEncoder, were trained on simulated PET datasets and evaluated on synthetic and real PET acquisitions from 68Ga-FH and 68Ga-PSMA-617 mouse studies. Performance was compared to a standard Richardson-Lucy-based positron range correction (RL-PRC) method using metrics such as mean absolute error (MAE), structural similarity index (SSIM), contrast recovery (CR), and contrast-to-noise ratio (CNR). CNN-based methods achieved up to 19 percent SSIM improvement and 13 percent MAE reduction compared to RL-PRC. The Two-Channel model achieved the highest CR and CNR, recovering lung activity with 97 percent agreement to ground truth versus 77 percent for RL-PRC. Noise levels remained stable for CNN models (approximately 5.9 percent), while RL-PRC increased noise by 5.8 percent. In preclinical acquisitions, the Two-Channel model achieved the highest CNR across tissues while maintaining the lowest noise level (9.6 percent). Although no ground truth was available for real data, tumor delineation and spillover artifacts improved with the Two-Channel model. These findings highlight the potential of CNN-based PRC to enhance quantitative PET imaging, particularly for 68Ga. Future work will improve model generalization through domain adaptation and hybrid training strategies.

Identifiers

PMID41675347
PMCPMC12889857

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.